Anthony Sandrasagra
Chief Scientific Officer,
Alevian Inc.
Anthony is a seasoned biotech and pharma leader with over 25 years driving discovery and development from target ID through early clinical studies His deep expertise spans proteomics, genomics, bioinformatics, screening, pharmacology and lead-optimization across recombinant proteins, antibodies, small molecules, oligonucleotides, and cell/gene therapies for multiple indications. He has held senior roles including CSO at Alevian (formerly Elevian), CSO at Provasculon, VP New Product Development at Mesoblast, and Head of Gene Expression & Proteomics at HMR Pharmaceuticals/Aventis (Sanofi predecessors). A named inventor on 20+ drug patents, he brings a proven track record of translating cutting-edge science into therapeutic candidates.